tirzepatide/b6 side effects Mounjaro (Tirzepatide) Effects: Your Month-by-Month Guide Has anyone had side effects

Proper site rotation and using a fresh needle each time minimizes these reactions

dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

GLP-1 receptor agonists in the treatment of type 2 diabetes state-of-the-art

It may be formulated differently based on patient needs

Current and Emerging Medications: Name Type Status Tirzepatide Dual GLP-1 / GIP Agonist FDA Approved CagriSema Dual GLP-1 / Amylin AgonistIn Phase 3 Trials Retatrutide Triple GIP / GLP-1 / GlucagonIn Phase 3 Trials These multi-pathway drugs aim to improve results but may also come with more side effects